Psychosis NOS
11
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
50%
4 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
Cognitive Strategies in Early Psychosis 2
Minnesota Community-Based Cognitive Training in Early Psychosis
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients
Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder
Simvastatin Addition for Patients With Recent-onset Schizophrenia
RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient Setting
Cognitive Behavioral Social Skills Training in Early Onset Psychosis
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Improving Care and Reducing Cost Study
Omega-3 Dietary Supplements in Schizophrenia
Cognitive Remediation in Early Phase Psychosis